Deerfield, United States
Baxter's investment strategy targets therapeutic areas that support its existing critical care, hospital, nutritional, renal and surgical offerings. Additionally, investments in emerging technologies and treatments not currently within the scope of Baxter's product portfolio are also prioritized.
12
Total Investments
12
Portfolio Companies
-
Exits
4
Industries
General Information
Industries
Biotechnology, Health Care +2
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Baxter Ventures
Recent Investments (12)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series C | •••••• | Jun 2021 | |
| Venture Round | •••••• | Oct 2020 | |
| Series C | •••••• | Sep 2020 | |
| Series B | •••••• | Nov 2018 | |
| Series D | •••••• | Aug 2018 | |
•••• ••••
|
Series C | •••••• | Oct 2017 |
|
•••• ••••
|
Venture Round | •••••• | Jul 2017 |
|
•••• ••••
|
Series C | •••••• | Jun 2016 |
|
•••• ••••
|
Series A | •••••• | Oct 2015 |
|
•••• ••••
|
Series A | •••••• | May 2015 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
